StemCell2MAX

Portugal
Cantanhede, Coimbra, Portugal, 3060-197

Company profile

StemCell2MAX company profile

StemCell2MAX is a Portuguese biotechnology company with the goal to address the global shortage of high-quality blood/haematopoietic stem cells (HSCs) for both medical and research use. The company has a strong IP position (EU, USA and Japan) on a highly innovative technology that selectively promotes survival and multiplication of highly scarce HSCs (Fonseca-Pereira, et al., Nature 514, 2014). In 2015, StemCell2MAX launched a research use only (RUO) expansion product and achieved a growing sales track record internationally and is currently developing the clinical use of its technology.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-05-14

Headquarters

Postal code
3060-197
Country code
PT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Last funding
Grant / 2016-01-01
Last equity funding
Seed
Investors
2
Lead investors
1
Founders
5
Articles
4

Founders and investors

Founders

Diogo Fonseca-PereiraFilipa Matos BaptistaJosé Henrique Veiga-FernandesMaria Brandão de VasconcelosSílvia Arroz-Madeira

Lead investors

Horizon 2020

Investors

Bynd Venture CapitalHorizon 2020